Science News : ACC 2012 : Monday

Updated:Mar 26,2012
email-header-ACC-2012


Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials - Session 305 (8:00 a.m.)

acc12_sslides_lamyCORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study
André Lamy, MD, MHSc, on behalf of the CORONARY Study Investigators, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Canada
Video interview (English)  |  Video Interview (French)  |  Summary slide
  
 acc12_pslides_litt_14ACRIN PA 4005: Multicenter Randomized Controlled Study of a Rapid “Rule Out” Strategy Using CT Coronary Angiogram Versus Traditional Care for Low-Risk ED Patients with Potential Acute Coronary Syndromes 
Harold Litt, University of Pennsylvania, Philadelphia
Presentation slides  |  Summary slide
  
acc12_sslides_bullerOral Rivaroxaban Alone for Symptomatic Pulmonary Embolism: The EINSTEIN PE Study
Harry Roger Buller, Academic Medical Center, Amsterdam, The Netherlands
Summary slide
  
acc12_sslides_leon-[Compatibility-Mode]Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of the PARTNER Trial
Martin Leon for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, N.Y.
Summary slide  |  Video interview


Late-Breaking Clinical Trials IV - Session 306
acc12_sslides_schauerComparison of Bariatric Surgical Procedures and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Patients with Moderate Obesity: 1-year STAMPEDE Trial Results
Philip Raymond Schauer, Cleveland Clinic, Cleveland
Summary slide  |  Video interview
  
 acc12_sslides_ferenceA Mendelian Randomized Controlled Trial of Long Term Reduction in Low-Density Lipoprotein Cholesterol Beginning Early in Life
Brian Anthony Ference, Wayne State University School of Medicine, Detroit, Mich.
Summary slide
  
acc12_pslides_mckenney-4A Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, REGN727/SAR236553, in Patients with Primary Hypercholesterolemia (NCT: 01288443)
James McKenney, PharmD, Regeneron Pharmaceuticals, Incorporated, Tarrytown, N.Y.
Presentation slides  |  Summary slide  |  Video interview
  
acc12_sslides_brignole-[Compatibility-Mode]Pacemaker Therapy in Patients with Neurally-mediated Syncope and Documented Asystole 
Michele Brignole, MD, on the behalf of the ISSUE-3 investigators, Ospedali del Tigullio, Lavagna, Italy
Summary slide  |  Video interview


Monoclonal Antibody and Hypercholeste...

Pacemaker Therapy in Patients with Ne...




heartorg-homebanner-ss12

PARTNER : ACC 2012

STAMPEDE : ACC 2012

CORONARY : ACC 2012

Science News On-the-Go (ACC 2012)

Download the below MP3 files and listen to each interview on your mobile, in your own time.
Audio IconCPORT-E
Download MP3
Audio IconSafety and Efficacy of a Monoclonal Antibody...
Download MP3
Audio IconCORONARY
MP3 (English)
  |  MP3 (French)
Audio IconISSUE-3
MP3 (English)  |  MP3 (Italian)
Audio IconBRIDGE-ACS
Download MP3
Audio IconFOCUS
Download MP3
Audio IconINFUSE-AMI
Download MP3
Audio IconTIMI 50 Trial
Download MP3
Audio IconWelcome to ACC 2012 (Donna Arnett & Gordon Tomaselli)
Download MP3
Noticias Cientificas
Summer 2014

To submit feedback or to subscribe, follow @AHAScience (opens in new window) on Twitter and use #NoticiasCientíficas (opens in new window).